These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1219 related items for PubMed ID: 19138340

  • 1. Neuromyelitis optica-IgG in idiopathic inflammatory demyelinating disorders amongst Hong Kong Chinese.
    Chan KH, Ramsden DB, Yu YL, Kwok KH, Chu AC, Ho PW, Kwan JS, Lee R, Lim E, Kung MH, Ho SL.
    Eur J Neurol; 2009 Mar; 16(3):310-6. PubMed ID: 19138340
    [Abstract] [Full Text] [Related]

  • 2. [Prognostic value of aquaporin-4 antibody in patients of inflammatory demyelinating diseases in central nervous system].
    Yang Y, Wu WP, Huang DH, Wu L.
    Zhonghua Yi Xue Za Zhi; 2012 Nov 20; 92(43):3032-5. PubMed ID: 23328372
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Neuromyelitis optica antibodies in patients with severe optic neuritis in China.
    Lai C, Tian G, Takahashi T, Liu W, Yang L, Zhang X.
    J Neuroophthalmol; 2011 Mar 20; 31(1):16-9. PubMed ID: 21150455
    [Abstract] [Full Text] [Related]

  • 8. Neuromyelitis optica-IgG (aquaporin-4) autoantibodies in immune mediated optic neuritis.
    Petzold A, Pittock S, Lennon V, Maggiore C, Weinshenker BG, Plant GT.
    J Neurol Neurosurg Psychiatry; 2010 Jan 20; 81(1):109-11. PubMed ID: 20019228
    [Abstract] [Full Text] [Related]

  • 9. NMO-IgG and Devic's neuromyelitis optica: a French experience.
    Marignier R, De Sèze J, Vukusic S, Durand-Dubief F, Zéphir H, Vermersch P, Cabre P, Cavillon G, Honnorat J, Confavreux C.
    Mult Scler; 2008 May 20; 14(4):440-5. PubMed ID: 18208892
    [Abstract] [Full Text] [Related]

  • 10. Neuromyelitis optica and non organ-specific autoimmunity.
    Pittock SJ, Lennon VA, de Seze J, Vermersch P, Homburger HA, Wingerchuk DM, Lucchinetti CF, Zéphir H, Moder K, Weinshenker BG.
    Arch Neurol; 2008 Jan 20; 65(1):78-83. PubMed ID: 18195142
    [Abstract] [Full Text] [Related]

  • 11. Aquaporin 4 antibody [NMO Ab] status in patients with severe optic neuritis in India.
    Ambika S, Balasubramanian M, Theresa L, Veeraputhiran A, Arjundas D.
    Int Ophthalmol; 2015 Dec 20; 35(6):801-6. PubMed ID: 25682013
    [Abstract] [Full Text] [Related]

  • 12. Antibodies target microvessels in neuromyelitis optica and multiple sclerosis patients.
    Long Y, Gao C, Qiu W, Hu X, Peng F, Lu Z.
    Neurol Res; 2013 Nov 20; 35(9):922-9. PubMed ID: 23845827
    [Abstract] [Full Text] [Related]

  • 13. Differential regulation of IgG-NMO autoantibodies on S100Beta protein and disability in relapsing neuromyelitis optica.
    Robinson-Agramonte MA, Gonçalves CA, Portela LV, Saiz-Hinarejos A, Oses JP, Motta LS, Muller AP, Marquez Gonzalez ME, Souza DO.
    Neuroimmunomodulation; 2010 Nov 20; 17(3):177-9. PubMed ID: 20134196
    [Abstract] [Full Text] [Related]

  • 14. Clinical features and sera anti-aquaporin 4 antibody positivity in patients with demyelinating disorders of the central nervous system from Tianjin, China.
    Yang CS, Zhang DQ, Wang JH, Jin WN, Li MS, Liu J, Zhang CJ, Li T, Shi FD, Yang L.
    CNS Neurosci Ther; 2014 Jan 20; 20(1):32-9. PubMed ID: 23890015
    [Abstract] [Full Text] [Related]

  • 15. Prediction of neuromyelitis optica attack severity by quantitation of complement-mediated injury to aquaporin-4-expressing cells.
    Hinson SR, McKeon A, Fryer JP, Apiwattanakul M, Lennon VA, Pittock SJ.
    Arch Neurol; 2009 Sep 20; 66(9):1164-7. PubMed ID: 19752309
    [Abstract] [Full Text] [Related]

  • 16. Central nervous system inflammatory demyelinating disorders among Hong Kong Chinese.
    Chan KH, Lee R, Lee JC, Tse AC, Pang SY, Lau GK, Teo KC, Ho PW.
    J Neuroimmunol; 2013 Sep 15; 262(1-2):100-5. PubMed ID: 23838529
    [Abstract] [Full Text] [Related]

  • 17. Neuromyelitis optica (NMO) antibody positivity in patients with transverse myelitis and no visual manifestations.
    Hamnik SE, Hacein-Bey L, Biller J, Gruener G, Jay W.
    Semin Ophthalmol; 2008 Sep 15; 23(3):191-200. PubMed ID: 18432545
    [Abstract] [Full Text] [Related]

  • 18. Seroprevalence of NMO-IgG Antibody in Neuromyelitis optica (NMO) and Its Specificity in Differentiating NMO from Other Demyelinating Diseases with Overlap Symptoms: An Iranian Experience.
    Harirchian MH, Tafakhori A, Taslimi S, Aghamollaii V, Shahsiah R, Gholipour T, Mohammadi F, Zare-Shahabadi A.
    Iran J Allergy Asthma Immunol; 2015 Feb 15; 14(1):98-104. PubMed ID: 25530145
    [Abstract] [Full Text] [Related]

  • 19. Idiopathic inflammatory demyelinating disorders after acute transverse myelitis.
    Chan KH, Tsang KL, Fong GC, Ho SL, Cheung RT, Mak W.
    Eur J Neurol; 2006 Aug 15; 13(8):862-8. PubMed ID: 16879297
    [Abstract] [Full Text] [Related]

  • 20. [Inflammation of the optic nerve: when it should be considered as neuromyelitis optica--the experience of the Department of Neurology at Hadassah Hospital].
    Vaknin-Dembinsky A, Levin N, Raz N, Abramsky O, Karussis D, Brill L, Petrou P, Ovadia H.
    Harefuah; 2013 Feb 15; 152(2):101-5, 122. PubMed ID: 23513502
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 61.